HeimOCEAW • OTCMKTS
add
Ocean Biomedical
Við síðustu lokun
0,0070 $
Árabil
0,0025 $ - 0,18 $
Markaðsvirði
1,04 m. USD
Meðalmagn
25,06 þ.
Viðskiptafréttir
CNBC
fyrir 39 mínútum
CNBC Daily Open: The health of the U.S. economy can depend on your viewing angle
0,22%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | — | — |
Rekstrarkostnaður | 958,00 þ. | 61,01% |
Nettótekjur | -8,24 m. | -163,39% |
Hagnaðarhlutfall | — | — |
Hagnaður á hvern hlut | — | — |
EBITDA | — | — |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | — | — |
Heildareignir | 1,58 m. | -46,30% |
Heildarskuldir | 93,98 m. | 19,37% |
Eigið fé alls | -92,40 m. | — |
Útistandandi hlutabréf | 91,02 m. | — |
Eiginfjárgengi | -0,01 | — |
Arðsemi eigna | -192,83% | — |
Ávöxtun eigin fjár | 3,16% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -8,24 m. | -163,39% |
Handbært fé frá rekstri | -356,00 þ. | 26,60% |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | 909,00 þ. | — |
Breyting á handbæru fé | 553,00 þ. | 214,02% |
Frjálst peningaflæði | -1,82 m. | -159,87% |
Um
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Stofnsett
2019
Höfuðstöðvar
Vefsvæði
Starfsfólk
7
